tiprankstipranks
Advertisement
Advertisement
Aspire Biopharma Completes $21 Million Private Placement Financing
PremiumCompany AnnouncementsAspire Biopharma Completes $21 Million Private Placement Financing
21d ago
Aspire Biopharma Shareholders Approve Major Capital Structure Changes
Premium
Company Announcements
Aspire Biopharma Shareholders Approve Major Capital Structure Changes
21d ago
Aspire Biopharma Plans Transformative Acquisition of Dura Driver
Premium
Company Announcements
Aspire Biopharma Plans Transformative Acquisition of Dura Driver
22d ago
Aspire Biopharma launches BUZZ BOMB Covenience Store Pack
PremiumThe FlyAspire Biopharma launches BUZZ BOMB Covenience Store Pack
2M ago
Aspire Biopharma, Microsize partner for sublingual alprazolam formulation
Premium
The Fly
Aspire Biopharma, Microsize partner for sublingual alprazolam formulation
2M ago
Aspire Biopharma’s Buzz Bomb announces expansion of social media footprint
Premium
The Fly
Aspire Biopharma’s Buzz Bomb announces expansion of social media footprint
2M ago
Aspire Biopharma appoints Phillip Balatsos to board of directors
PremiumThe FlyAspire Biopharma appoints Phillip Balatsos to board of directors
3M ago
Aspire Biopharma Announces Private Placement to Strengthen Finances
Premium
Company Announcements
Aspire Biopharma Announces Private Placement to Strengthen Finances
3M ago
Aspire Biopharma files patent application for sublingual ondansetron formulation
Premium
The Fly
Aspire Biopharma files patent application for sublingual ondansetron formulation
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100